Integrin α3 is involved in non-enveloped hepatitis E virus infection-Reference-Cited by-同舟云学术

Integrin α3 is involved in non-enveloped hepatitis E virus infection

Published:2019-10 Issue: Volume:536 Page:119-124
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Shiota Tomoyuki,Li Tian-Cheng,Nishimura Yorihiro,Yoshizaki Sayaka,Sugiyama Ryuichi,Shimojima Masayuki,Saijo Masayuki,Shimizu Hiroyuki,Suzuki Ryosuke,Wakita Takaji,Muramatsu Masamichi,Ishii Koji

Funder

Research Resident Program and grants-in-aid from AMED

grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan

Sasakawa Scientific Research Foundation from the Japan Science Society

JSPS KAKENHI

Publisher

Elsevier BV

Subject

Virology

Reference37 articles.

1. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells;Akula;Cell,2002

2. Differential expression of the VLA family of integrins along the crypt-villus axis in the human small intestine;Beaulieu;J. Cell Sci.,1992

3. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan;Boccia;Clin. Infect. Dis.,2006

4. Integrin structure, activation, and interactions;Campbell;Cold Spring Harb. Perspect. Biol.,2011

5. Expression of the VLA family of integrins in human intestine;Choy;J. Pathol.,1990

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis E Virus: What More Do We Need to Know?;Medicina;2024-06-18

2. Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection;Hepatology Research;2024-06-14

3. Targeting cellular cathepsins inhibits hepatitis E virus entry;Hepatology;2024-05-10

4. Targeting cellular cathepsins inhibits hepatitis E virus infection;2023-11-05

5. A high-content RNA-based imaging assay reveals integrin beta 1 as a cofactor for cell entry of non-enveloped hepatitis E virus;2023-10-27